Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
- 10 October 2014
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 346 (6206), 251-256
- https://doi.org/10.1126/science.1253462
Abstract
Spatial and temporal dissection of the genomic changes occurring during the evolution of human non–small cell lung cancer (NSCLC) may help elucidate the basis for its dismal prognosis. We sequenced 25 spatially distinct regions from seven operable NSCLCs and found evidence of branched evolution, with driver mutations arising before and after subclonal diversification. There was pronounced intratumor heterogeneity in copy number alterations, translocations, and mutations associated with APOBEC cytidine deaminase activity. Despite maintained carcinogen exposure, tumors from smokers showed a relative decrease in smoking-related mutations over time, accompanied by an increase in APOBEC-associated mutations. In tumors from former smokers, genome-doubling occurred within a smoking-signature context before subclonal diversification, which suggested that a long period of tumor latency had preceded clinical detection. The regionally separated driver mutations, coupled with the relentless and heterogeneous nature of the genome instability processes, are likely to confound treatment success in NSCLC.Keywords
This publication has 61 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Diverse Mechanisms of Somatic Structural Variations in Human Cancer GenomesCell, 2013
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- The Life History of 21 Breast CancersCell, 2012
- dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictionsHuman Mutation, 2011
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinomaNature, 2011
- Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawalNature, 2010
- A small-cell lung cancer genome with complex signatures of tobacco exposureNature, 2009
- Characterizing the cancer genome in lung adenocarcinomaNature, 2007
- Mutations of the BRAF gene in human cancerNature, 2002